Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Trovagene Names Cantor to SAB; WaferGen Hires Two Managers


Trovagene said this week that Charles Cantor has joined the company's scientific advisory board.

Cantor is currently adjunct professor of bioengineering at the University of California, San Diego; adjunct professor of molecular biology at the Scripps Research Institute; and distinguished adjunct professor of physiology and biophysics at the University of California, Irvine. He is also professor emeritus of biomedical engineering and pharmacology, and was the director of the Center for Advanced Biotechnology at Boston University.

Cantor also is a founder and former CSO of Sequenom. One of the leaders of the Human Genome Project, he has published more than 400 peer-reviewed articles, and authored and co-authored more than 50 US and international patents.

WaferGen Biosystems said this week during its 2013 earnings call that Maithreyan Srinivasan has joined the company as chief technology officer, and Nicolas Bardonnet has joined the firm as managing director for Europe.

Srinivasan is formerly a senior director of R&D at Agilent Technologies and director of molecular biology R&D at 454 Life Sciences/Roche Diagnostics. Bardonnet previously served as president of Qiagen France, and vice president of sales and marketing at Imagene.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.